18 May 2013
Keywords: teturna, cuts, level, proteinuria, diabetics, swiss, drug
Article | 19 November 2007
Swiss drug firm Speedel says that data from a Phase III trial of Tekturna (aliskiren, known as Rasilez in Europe) ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
19 November 2007
17 May 2013
© 2013 thepharmaletter.com